Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> Aurobindo Gets FDA Nod for Provigil Generic
FDAnews Drug Daily Bulletin
Oct. 1, 2012
| Vol. 9 No. 192
Aurobindo Gets FDA Nod for Provigil Generic
Aurobindo Pharma has received approval from the FDA to manufacture and market modafinil tablets of 100 mg and 200 mg.
The Hindu Business Line
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Full Issue
FDA Advisers Recommend Merck Insomnia Drug; Downplay Need for Additional Trials
Senate Preps Track-and-Trace, Compounding Reform Bills for Floor Vote
Ranbaxy Compliance Reforms Reflect FDA Manufacturing Recommendations